P. Rampini

479 total citations
19 papers, 368 citations indexed

About

P. Rampini is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Reproductive Medicine. According to data from OpenAlex, P. Rampini has authored 19 papers receiving a total of 368 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Surgery and 3 papers in Reproductive Medicine. Recurrent topics in P. Rampini's work include Pituitary Gland Disorders and Treatments (11 papers), Growth Hormone and Insulin-like Growth Factors (11 papers) and Adrenal and Paraganglionic Tumors (4 papers). P. Rampini is often cited by papers focused on Pituitary Gland Disorders and Treatments (11 papers), Growth Hormone and Insulin-like Growth Factors (11 papers) and Adrenal and Paraganglionic Tumors (4 papers). P. Rampini collaborates with scholars based in Italy and United Kingdom. P. Rampini's co-authors include Roberto Caldara, Carlo Ferrari, Giovanni Ferrari, Pier Giorgio Crosignani, Franco Borzio, Mauro Borzio, M. Romussi, C. Scarduelli, A. Paracchi and F. Mailland and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes Care and Gut.

In The Last Decade

P. Rampini

19 papers receiving 336 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Rampini Italy 9 218 63 62 60 56 19 368
K. H. Usadel Germany 9 208 1.0× 50 0.8× 47 0.8× 17 0.3× 24 0.4× 22 382
Lester Baker United States 8 170 0.8× 27 0.4× 55 0.9× 54 0.9× 22 0.4× 11 379
AB Grossman United Kingdom 7 216 1.0× 22 0.3× 78 1.3× 23 0.4× 214 3.8× 10 476
P Daggett United States 11 180 0.8× 19 0.3× 110 1.8× 11 0.2× 82 1.5× 28 367
Gerlach F. Pieters Netherlands 12 347 1.6× 30 0.5× 155 2.5× 40 0.7× 48 0.9× 21 473
Yonah B. Esterson United States 9 71 0.3× 24 0.4× 94 1.5× 15 0.3× 101 1.8× 19 296
Takeshi Komeyama Japan 10 204 0.9× 20 0.3× 195 3.1× 29 0.5× 32 0.6× 41 434
Malgorzata Monika Brzozowska Australia 8 90 0.4× 40 0.6× 132 2.1× 8 0.1× 93 1.7× 22 352
Takehiko Tominaga Japan 4 188 0.9× 202 3.2× 44 0.7× 9 0.1× 8 0.1× 7 398
J Sowiński Poland 11 131 0.6× 29 0.5× 44 0.7× 36 0.6× 94 1.7× 35 393

Countries citing papers authored by P. Rampini

Since Specialization
Citations

This map shows the geographic impact of P. Rampini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Rampini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Rampini more than expected).

Fields of papers citing papers by P. Rampini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Rampini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Rampini. The network helps show where P. Rampini may publish in the future.

Co-authorship network of co-authors of P. Rampini

This figure shows the co-authorship network connecting the top 25 collaborators of P. Rampini. A scholar is included among the top collaborators of P. Rampini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Rampini. P. Rampini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Faglia, Ezio, Fabrizio Favales, Patrizia Calia, et al.. (2002). Cardiac Events in 735 Type 2 Diabetic Patients Who Underwent Screening for Unknown Asymptomatic Coronary Heart Disease. Diabetes Care. 25(11). 2032–2036. 79 indexed citations
2.
Ferrari, Giovanni, et al.. (1987). Serum free thyroid hormones in different degrees of hypothyroidism and in euthyroid autoimmune thyroiditis. European Journal of Endocrinology. 114(4). 559–564. 8 indexed citations
3.
Mattei, A, Carlo Ferrari, G. Ragni, et al.. (1984). Serum prolactin and ovarian function after discontinuation of drug treatment for hyperprolactinaemia: a study with bromocriptine and metergoline. BJOG An International Journal of Obstetrics & Gynaecology. 91(3). 244–250. 11 indexed citations
4.
Ferrari, Giovanni, et al.. (1983). Serum free thyroid hormones in T3-toxicosis: a study of 35 patients. Journal of Endocrinological Investigation. 6(1). 55–58. 3 indexed citations
5.
Borzio, Mauro, et al.. (1983). Thyroid function tests in chronic liver disease: evidence for multiple abnormalities despite clinical euthyroidism.. Gut. 24(7). 631–636. 70 indexed citations
7.
Boghen, M., et al.. (1983). Thyroid autoimmunity in hyperprolactinaemic disorders. European Journal of Endocrinology. 104(1). 35–41. 45 indexed citations
8.
Ferrari, Carlo, et al.. (1983). Effects of ibopamine on serum prolactin and growth hormone levels in hyperprolactinemic and acromegalic subjects. Clinical Pharmacology & Therapeutics. 34(1). 74–78. 6 indexed citations
9.
Ferrari, Carlo, C. Scarduelli, P. Rampini, et al.. (1983). Prolactin Response to the Dopamine Antagonists Sulpiride and Domperidone. Gynecologic and Obstetric Investigation. 16(5). 299–306. 1 indexed citations
10.
Crosignani, Pier Giorgio, Carlo Ferrari, Antonio Liuzzi, et al.. (1982). Treatment of hyperprolactinemic states with different drugs: a study with bromocriptine, metergoline, and lisuride. Fertility and Sterility. 37(1). 61–67. 33 indexed citations
11.
Ferrari, Carlo, et al.. (1982). Functional Characterization of Hypothalamic Hyperprolactinemia*. The Journal of Clinical Endocrinology & Metabolism. 55(5). 897–901. 19 indexed citations
12.
Caldara, Roberto, et al.. (1982). Effect of labetalol, an alpha‐and beta‐adrenoceptor antagonist, on gastric acid and gastrin secretion in man.. British Journal of Clinical Pharmacology. 14(5). 744–746. 1 indexed citations
13.
Ferrari, Carlo, et al.. (1981). Effects of Chronic Prazosin Treatment on the Renin—Angiotensin—Aldosterone System in Man. The Journal of Clinical Pharmacology. 21(10). 418–423. 7 indexed citations
14.
Ferrari, Giovanni, et al.. (1981). Central Nervous System and Pituitary Mechanisms in Dopaminergic Stimulation of Growth Hormone Release in Women. Neuroendocrinology. 32(4). 213–216. 3 indexed citations
15.
Ferrari, Carlo, et al.. (1981). Inhibition of luteinizing hormone release by dopamine infusion in healthy women and in various pathophysiological conditions. European Journal of Endocrinology. 97(4). 436–440. 22 indexed citations
16.
Ferrari, Giovanni, et al.. (1980). Hyperprolactinemic Primary Amenorrhea: Case Report with Successful Prolactin-Lowering Treatment and Review of the Literature. Gynecologic and Obstetric Investigation. 11(6). 317–326. 1 indexed citations
17.
Ferrari, Carlo, et al.. (1980). Failure of Nomifensine Administration to Discriminate between Tumorous and Nontumorous Hyperprolactinemia*. The Journal of Clinical Endocrinology & Metabolism. 50(1). 23–26. 19 indexed citations
18.
Santis, A. De, C. A. Pagni, & P. Rampini. (1979). OSSERVAZIONI SUL CONTROLLO A DISTANZA DI 64 PAZIENTI CON CRISI PRECOCI POST-TRAUMATICHE. 43–46. 3 indexed citations
19.
Ferrari, Carlo, et al.. (1978). Restoration of Cyclic Ovarian Function by Metergoline Treatment in a Patient with a Prolactin-Secreting Pituitary Microadenoma. Fertility and Sterility. 30(2). 237–239. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026